128940.KS
Hanmi Pharmaceutical Co., Ltd. [128940.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
128940.KS Stock Summary
Top 10 Correlated ETFs
128940.KS
Top 10 Correlated Stocks
128940.KS
In the News
128940.KS Financial details
Company Rating
-
Market Cap
4009.45B
Income
146.23B
Revenue
1490.89B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.24K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
33.17
Forward P/E
-
PEG
4.27
P/S
3.13
P/B
4.53
P/C
-
P/FCF
44.44
Quick Ratio
-
Current Ratio
1.07
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
11.58K
EPS next Y
-
EPS next Q
-
EPS this Y
76.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
23.51%
Revenue last 5Y
6.01%
Revenue Q/Q
15.84%
EPS Q/Q
-35.87%
-
-
-
-
SMA20
3.93%
SMA50
-6.81%
SMA100
-12.73%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
14%
ROC
0.15%
Gross Margin
55%
Oper. Margin
13%
Profit Margin
9%
Payout
20%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
256372.55-377000.0
52W High
-28.65%
52W Low
+4.93%
RSI
70.32
Rel Volume
5.48
Avg Volume
52.49K
Volume
287.72K
Perf Week
12.08%
Perf Month
9.35%
Perf Quarter
-12.23%
Perf Half Y
-17.99%
-
-
-
-
Beta
0.553
-
-
Volatility
9999.49%, 9060.31%
Prev Close
8.91%
Price
269000
Change
12.32%
Company Profile
- Volume Average 52.49K
- Market Capitalization 4009.45B
- Employee 2.24K
- CEO Mr. Jae-Hyun Park
- Headquarters Seoul,KR
- IPO Date 2010-07-30
-
Website
https://www.hanmipharm.com 
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
